Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
FemiFec, Prurirex
Synonyms :
cogomycin, fungichromin
Class :
Antibiotic macrolides
Brand Name :
FemiFec, Prurirex
Synonyms :
cogomycin, fungichromin
Class :
Antibiotic macrolides
Dosage forms & StrengthsÂ
Vaginal pessary:Â
3 mgÂ
10 mgÂ
Dry powder inhalation:Â
It is effective in treating respiratory aspergillosis Â
ADULT DOSING:Â
3-6 mg vaginal tablet once daily is indicated for the vaginal candidiasis, trichomoniasis, mixed infections.Â
3-10 mg of vaginal pessary is also indicated once/twice daily for vaginal infections.Â
No information availableÂ
Refer to adult dosingÂ
measles, mumps, rubella, and varicella vaccine, live (Rx)
may diminish the therapeutic effect
measles mumps and rubella vaccine, live
may diminish the therapeutic effect
may diminish the therapeutic effect
smallpox (vaccinia) vaccine, live
may diminish the therapeutic effect
may diminish the therapeutic effect
respiratory syncytial virus vaccine, adjuvanted
may decrease the therapeutic effect when combined with vaccine
respiratory syncytial virus (RSV) vaccine
may decrease the therapeutic effect when combined with vaccine
poliovirus vaccine, live, trivalent
may decrease the therapeutic effect when combined with vaccine
poliovirus vaccine inactivated
may decrease the therapeutic effect when combined with vaccine
may have an increased nephrotoxic effect when combined with aminoglycosides
neomycin/polymyxin B/bacitracin topical
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
may have an increased anticoagulant effect when combined with vitamin k antagonists
sodium picosulfate citric acid and magnesium oxide
it may reduce the therapeutic effect of sodium picosulfate
antibiotics may diminish the therapeutic effect of Bacillus clausii
antibiotics may diminish the therapeutic effect of Typhoid Vaccine
antibiotics may diminish the therapeutic effect of typhoid Vaccine
sodium picosulfate, citric acid, and magnesium oxideÂ
may decrease the therapeutic effect when combined with sodium picosulfate
may have an increased nephrotoxic effect when combined with colistimethate
antibiotics: they may decrease the therapeutic effect of sodium picosulfuric acid
lansoprazole, amoxicillin, and clarithromycin
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
meningococcal A C Y and W-135 diphtheria conjugate vaccine
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
there may be an increased risk of renal impairment
pentamycin increases the therapeutic efficacy of acenocoumarol when used in combination
pentamycin increases the therapeutic effectiveness of dicoumarol when used in combination
pentamycin increases the therapeutic efficacy of fluindione when used in combination
pentamycin increases the therapeutic efficacy of phenidione when used in combination
pentamycin increases the therapeutic effectiveness of phenprocoumon when used in combination
pentamycin increases the therapeutic efficacy of warfarin when used in combination
they increase the nephrotoxicity of other aminoglycosides
neomycin/polymyxin B/bacitracin topical
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
it may diminish the therapeutic effect of cholera Vaccine
antibiotics decrease the efficacy of intravesical BCG
antibiotics decrease the efficacy of cholera vaccine
may diminish the serum concentration of pencillins
neomycin/polymyxin B/gramicidin ophthalmicÂ
may increase the nephrotoxic effect of Polymyxin B
they increase the nephrotoxicity of other aminoglycosides
neomycin/polymyxin B/bacitracin topical
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
it increases the nephrotoxicity of aminoglycosides
it increases the nephrotoxicity of aminoglycosides
aminoglycosides increase the effect of neuromuscular blockage of mecamylamine
antibiotics decrease the efficacy of BCG intravesical
it decreases the efficacy of antibiotics
the adverse/toxic effects of aminoglycosides may be heightened by ataluren
the nephrotoxic effects of aminoglycosides may be enhanced by mannitol
may enhance the renal tubular clearance for anionic drug competition
may increase the serum concentration of Cardiac Glycosides
may increase the serum concentration of Cardiac Glycosides
may increase the serum concentration of Cardiac Glycosides
may increase the serum concentration of Cardiac Glycosides
may increase the serum concentration of Cardiac Glycosides
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
they increase the effect of hypocalcemia in bisphosphonate derivatives
they increase the effect of hypocalcemia in bisphosphonate derivatives
they increase the effect of hypocalcemia in bisphosphonate derivatives
they increase the effect of hypocalcemia in bisphosphonate derivatives
may enhance the hypocalcemic effect of bisphosphonate derivatives
may enhance the hypocalcemic effect of bisphosphonate derivatives
may enhance the hypocalcemic effect of bisphosphonate derivatives
may enhance the hypocalcemic effect of bisphosphonate derivatives
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
antibiotics may reduce the therapeutic effect of immune checkpoint inhibitors
antibiotics may reduce the therapeutic effect of immune checkpoint inhibitors
antibiotics may reduce the therapeutic effect of immune checkpoint inhibitors
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may enhance the hypocalcemic effect
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
aminoglycosides increase the effect of hypocalcemia of bisphosphonate derivatives
aminoglycosides increase the effect of hypocalcemia of bisphosphonate derivatives
aminoglycosides increase the effect of hypocalcemia of bisphosphonate derivatives
aminoglycosides increase the effect of hypocalcemia of bisphosphonate derivatives
aminoglycosides increase the effect of hypocalcemia of bisphosphonate derivatives
may diminish the concentration of serum when combined with cardiac glycosides
may diminish the concentration of serum when combined with cardiac glycosides
may diminish the concentration of serum when combined with cardiac glycosides
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased therapeutic effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
The harmful/toxic effect of aminoglycosides may be intensified by loop diuretics
The harmful/toxic effect of aminoglycosides may be intensified by loop diuretics
The harmful/toxic effect of aminoglycosides may be intensified by loop diuretics
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may have an increased hypoglycemic effect when combined with sulfonylureas
may have an increased hypoglycemic effect when combined with sulfonylureas
penicillins may decrease the serum concentration of Aminoglycosides
penicillins may decrease the serum concentration of Aminoglycosides
penicillins may decrease the serum concentration of Aminoglycosides
penicillins may decrease the serum concentration of Aminoglycosides
penicillins may decrease the serum concentration of Aminoglycosides
antibiotics may reduce the therapeutic effect of bcg Vaccine
penicillins may decrease the serum concentration of aminoglycosides.
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
antibiotics decrease the efficacy of lactobacillus
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may diminish the therapeutic effect of immune checkpoint inhibitors
may diminish the therapeutic effect of immune checkpoint inhibitors
may diminish the therapeutic effect of immune checkpoint inhibitors
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may decrease the excretion of non-steroidal anti-inflammatory drugs
loop diuretics may increase the risk of adverse effect of aminoglycosides
loop diuretics may increase the risk of adverse effect of aminoglycosides
loop diuretics may increase the risk of adverse effect of aminoglycosides
may increase the nephrotoxic effect of aminoglycosides
may increase the nephrotoxic effect of aminoglycosides
may increase the nephrotoxic effect of aminoglycosides
may increase the nephrotoxic effect of cephalosporins
may increase the anticoagulant effect of cephalosporins
may decrease the excretion of nonsteroidal anti-inflammatory agents
may have an increased neuromuscular-blocking effect when combined with botulinum toxin-containing products
may enhance the nephrotoxicity of aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may increase the nephrotoxic effect of Amphotericin B
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cyclosporine
Penicillins: they may diminish the serum concentration of aminoglycosides
amoxicillin and clavulanate potassium
Penicillins: they may diminish the serum concentration of aminoglycosides
Penicillins: they may diminish the serum concentration of aminoglycosides
Penicillins: they may diminish the serum concentration of aminoglycosides
Penicillins: they may diminish the serum concentration of aminoglycosides
it increases the nephrotoxicity of aminoglycosides
it increases the nephrotoxicity of aminoglycosides
it increases the effect of neuromuscular blockage of aminoglycosides
they increase the effect of nephrotoxicity of aminoglycosides
they increase the effect of nephrotoxicity of aminoglycosides
they increase the effect of nephrotoxicity of aminoglycosides
BCG Vaccine live: they may decrease the therapeutic effect of antibiotics
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may diminish the concentration of serum when combined with aminoglycosides
may diminish the concentration of serum when combined with aminoglycosides
may diminish the serum concentration when combined with aminoglycosides
may diminish the serum concentration when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
meningococcal A C Y and W-135 diphtheria conjugate vaccine
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
aminoglycosides may augment the ototoxic effect of carboplatin, particularly with higher doses of carboplatin
may diminish the excretion when combined with aminoglycosides
antibiotics decrease the efficacy of Bacillus clausii
antibiotics decrease the efficacy of typhoid vaccine
antibiotics decrease the efficacy of thiamine by altering the gut flora
Frequency defined:Â Â
>10%Â
Diarrhea Â
Nausea Â
Abdominal pain Â
Loose motion Â
1%-10%:Â
Pain at the injection siteÂ
VomitingÂ
Abdominal painÂ
Local inflammation Â
Frequency not defined:Â Â
DyspepsiaÂ
FlatulenceÂ
SomnolenceÂ
LeukopeniaÂ
NeutropeniaÂ
HeadacheÂ
GastritisÂ
Taste changeÂ
Pregnancy consideration: No data is available for the usage of pentamycin during pregnancy.Â
Lactation: No data available regarding the excretion of pentamycin in breast milk. Â
Pregnancy category:Â
Patient information leafletÂ
Generic Name: PentamycinÂ
Pronounced: pen-ta-my-sinÂ
Â
Why do we use pentamycin?Â
Pentamycin is a macrolide antibiotic. It treats mixed infections in the ear, respiratory tract, vagina, skin, and eye. Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
